SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-377065
Filing Date
2015-11-13
Accepted
2015-11-13 16:04:21
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d73725d10q.htm 10-Q 628459
2 EX-31.1 d73725dex311.htm EX-31.1 8637
3 EX-31.2 d73725dex312.htm EX-31.2 8640
4 EX-32.1 d73725dex321.htm EX-32.1 5376
  Complete submission text file 0001193125-15-377065.txt   3015556

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT zfgn-20150930.xml EX-101.INS 554715
6 XBRL TAXONOMY EXTENSION SCHEMA zfgn-20150930.xsd EX-101.SCH 33236
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zfgn-20150930_cal.xml EX-101.CAL 56094
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zfgn-20150930_def.xml EX-101.DEF 87542
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zfgn-20150930_lab.xml EX-101.LAB 265734
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zfgn-20150930_pre.xml EX-101.PRE 181788
Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36510 | Film No.: 151229149
SIC: 2834 Pharmaceutical Preparations